Matthew Daniels is the founder of Psivant Therapeutics. Psivant Therapeutics has raised $50M in total funding. Latest round: Series A.
Matthew Daniels is listed on LinkedIn as a Director in Medicinal Chemistry at Psivant Therapeutics, with that role shown as starting in October 2024. Public sources provided here do not establish him as a founder, and no independent source in the results confirms a founder title or detailed biography.
Full founder directory · Investor directory · Company funding database · Fundraising library